Data Knights Acquisition (NASDAQ:DKDCA – Get Rating) and Bioqual (OTCMKTS:BIOQ – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability and analyst recommendations.
Earnings and Valuation
This table compares Data Knights Acquisition and Bioqual's top-line revenue, earnings per share and valuation.
Get Data Knights Acquisition alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Data Knights Acquisition | N/A | N/A | $5.14 million | N/A | N/A |
| Bioqual | $66.15 million | 0.95 | $5.26 million | $5.89 | 11.88 |
Bioqual has higher revenue and earnings than Data Knights Acquisition.
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Data Knights Acquisition and Bioqual, as reported by MarketBeat.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Data Knights Acquisition | 0 | 0 | 0 | 0 | N/A |
| Bioqual | 0 | 0 | 0 | 0 | N/A |
Institutional and Insider Ownership
97.3% of Data Knights Acquisition shares are held by institutional investors. 39.2% of Bioqual shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk & Volatility
Data Knights Acquisition has a beta of -0.01, meaning that its stock price is 101% less volatile than the S&P 500. Comparatively, Bioqual has a beta of -0.18, meaning that its stock price is 118% less volatile than the S&P 500.
Profitability
This table compares Data Knights Acquisition and Bioqual's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Data Knights Acquisition | N/A | N/A | N/A |
| Bioqual | 7.92% | 14.90% | 8.53% |
Summary
Bioqual beats Data Knights Acquisition on 6 of the 8 factors compared between the two stocks.
About Data Knights Acquisition
(Get Rating)
Data Knights Acquisition Corp. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. The company was incorporated in 2021 and is based in Chessington, the United Kingdom.
About Bioqual
(Get Rating)
Bioqual, Inc. provides in-vivo and in-vitro pre-clinical research services to commercial and government clients in the United States. The company provides research services in the areas of COVID-19, AIDS, influenza, RSV infection, and flavivirus infections, including zika, dengue, malaria, hepatitis, and cancer. Its services also include sample processing, virus stock generation, quantitation of infectious virus, virus neutralization assays, hemagglutination inhibition assay, quantitative PCR, antigen and antibody ELISA detection assays, flow cytometry, lymphocyte proliferation, and other cell-based assays. In addition, the company provides animal research model related services. Bioqual, Inc. was founded in 1981 and is headquartered in Rockville, Maryland.
Receive News & Ratings for Data Knights Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Data Knights Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.